Screening for Pancreatic Cancer Gets a D, but the Student Is Improving

Affiliations

¹ Sol Goldman Pancreatic Cancer Research Center, Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Surgery, Massachusetts General Hospital, Boston.

Editorial

Ralph H Hruban et al. JAMA Surg. 2019.

. 2019 Sep 1;154(9):795-797.

doi: 10.1001/jamasurg.2019.2832.

¹ Sol Goldman Pancreatic Cancer Research Center, Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Department of Surgery, Massachusetts General Hospital, Boston.

No abstract available

Comment on

Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henrikson NB, Aiello Bowles EJ, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, Lin JS. Henrikson NB, et al. JAMA. 2019 Aug 6;322(5):445-454. doi: 10.1001/jama.2019.6190. JAMA. 2019. PMID: 31386140
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.
US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Curry SJ, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Aug 6;322(5):438-444. doi: 10.1001/jama.2019.10232. JAMA. 2019. PMID: 31386141